ARDX (STOCKS)
Ardelyx, Inc.
$6.330000
+0.150000 (+2.43%)
Prev close: $6.180000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Michael G. Raab
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,551.19M
- Employees
- 395
- P/E (TTM)
- -23.99
- P/B (TTM)
- 9.05
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
10
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.00 | $0.01 | -0.0129 | -100.00% |
|
Sep 2025 (Q3)
|
$0.00 | $-0.06 | +0.0589 | +100.00% |
|
Jun 2025 (Q2)
|
$-0.08 | $-0.14 | +0.0562 | +41.26% |
|
Mar 2025 (Q1)
|
$-0.17 | $-0.12 | -0.0541 | -46.68% |
Financial Statements
| Revenues | $407.32M |
| Benefits Costs and Expenses | $467.95M |
| Cost Of Revenue | $39.54M |
| Costs And Expenses | $448.30M |
| Gross Profit | $367.78M |
| Nonoperating Income/Loss | $8.75M |
| Operating Expenses | $408.76M |
| Selling, General, and Administrative Expenses | $337.23M |
| Research and Development | $71.53M |
| Operating Income/Loss | -$40.98M |
| Income/Loss From Continuing Operations After Tax | -$61.60M |
| Income/Loss From Continuing Operations Before Tax | -$60.63M |
| Income Tax Expense/Benefit | $969.00K |
| Income Tax Expense/Benefit, Current | $969.00K |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$61.60M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$61.60M |
| Net Income/Loss Available To Common Stockholders, Basic | -$61.60M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.26 |
| Diluted Earnings Per Share | -$0.26 |
| Basic Average Shares | 241,033,750 |
| Diluted Average Shares | 241,033,750 |
| Assets | $501.60M |
| Current Assets | $382.32M |
| Inventory | $123.11M |
| Other Current Assets | $259.21M |
| Noncurrent Assets | $119.29M |
| Fixed Assets | $2.18M |
| Other Non-current Assets | $117.10M |
| Liabilities | $334.66M |
| Current Liabilities | $88.61M |
| Accounts Payable | $19.24M |
| Wages | $19.11M |
| Other Current Liabilities | $50.26M |
| Noncurrent Liabilities | $246.05M |
| Long-term Debt | $202.83M |
| Other Non-current Liabilities | $43.22M |
| Equity | $166.95M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $166.95M |
| Liabilities And Equity | $501.60M |
| Net Cash Flow From Operating Activities | -$42.48M |
| Net Cash Flow From Operating Activities, Continuing | -$42.48M |
| Net Cash Flow From Investing Activities | -$8.96M |
| Net Cash Flow From Investing Activities, Continuing | -$8.96M |
| Net Cash Flow From Financing Activities | $54.51M |
| Net Cash Flow From Financing Activities, Continuing | $54.51M |
| Net Cash Flow | $3.07M |
| Net Cash Flow, Continuing | $3.07M |
| Comprehensive Income/Loss | -$61.46M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$61.46M |
| Other Comprehensive Income/Loss | -$61.46M |